National and Kapodistrian University of Athens
Επίπεδα αγγειακού ενδοθηλιακού αυξητικού παράγοντα (vegf) σε ασθενείς με χρόνια ηπατική νόσο
Abstract
dc:descriptionAim of the study: To assess the significance of vascular endothelial growth factor (VEGF) serum levels in non-alcoholic fatty liver disease (NAFLD).Material and Methods: Sixty-seven consecutive NAFLD patients and 47 healthy controls who visited our liver clinics between May 2008 and December 2010 were included. NAFLD diagnosis required elevated alanine aminotransferase (ALT) and/or gamma-glutamyl transpeptidase (GGT) levels, evidence of hepatic steatosis on ultrasound and/or liver histology and exclusion of other causes of liver injury. Serum VEGF levels were determined by an enzyme immunossay. Liver biopsy was obtained in 34 NAFLD patients. Histological lesions were scored by a liver histopathologist.Results: Serum VEGF levels tended to be lower in matched NAFLD patients than healthy controls (296±146 vs 365±186 pg/mL, p=0.092) or in patients with non-alcoholic steatohepatitis (NASH) than with simple fatty liver (279±149 vs 359±190 pg/mL, P=0.095) and were significantly lower in NASH patients than healthy controls (279±149 vs 365±186 pg/mL, p=0.041). VEGF levels offered poor predictability for the differentiation between NAFLD patients and controls or NASH and fatty liver patients. However, patients with high (≥300 pg/mL) than low (<300 pg/mL) VEGF levels have had significantly more frequently simple fatty liver in the total NAFLD population (67% vs 35%, P=0.019) or in the 34 NAFLD patients with liver biopsy (57% vs 15%, P=0.023) and had significantly lower mean fibrosis score (0.7±0.9 vs 1.6±1.0, P=0.017).Conclusions: Our data suggest that serum VEGF levels are similarly high in healthy controls and patients with simple fatty liver and tend to decrease when NASH develops.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papageorgiou, Maria-Vasiliki
- Παπαγεωργίου, Μαρία-Βασιλική
Subjects
dc:subject × 14- Μη αλκοολική λιπώδης νόσος του ήπατος
- Μη αλκοολική στεατοηπατίτιδα
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Υποδοχείς αγγειακού ενδοθηλιακού αυξητικού παράγοντα
- Δείκτες αγγειογένεσης
- Non alcoholic fatty liver disease
- Non alcoholic steatohepatitis
- Vascular endothelial growth factor (VEGF)
- Vascular endothelial growth factor receptors
- Angiogenesis markers
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39959